Galcanezumab for prevention of episodic and chronic migraine in real life in Colombia and Mexico: a multicenter prospective cohort study

被引：0

作者：

Munoz-Ceron, J. ^{[1
,2
]}

Velez, K. ^{[3
]}

Rodriguez, I. ^{[3
]}

Hernandez, N. ^{[4
]}

Guerra, C. ^{[4
,5
]}

Bohorquez, S. ^{[6
]}

Jimenez, J. D. ^{[7
]}

Moreno, C. ^{[2
,8
]}

Ramos, M. ^{[9
]}

Cavanzo, P. ^{[9
]}

Rojas, Y. ^{[10
]}

Bernal, R. ^{[10
]}

Lopez, R. ^{[11
]}

Gallo, L. ^{[1
]}

机构：

[1] Hosp Univ Mayor Mederi CIMED, Neurol, Bogota, Colombia

[2] Clin Univ Colombia Keralty, Bogota, Colombia

[3] Asociac Mexicana Cefaleas & MIgrana AC, Mexico City, DF, Mexico

[4] SURA, Medellin, Colombia

[5] Clin SOMA, Medellin, Colombia

[6] Hosp Kennedy, Bogota, Colombia

[7] ACN, Pereira, Colombia

[8] ACN, Bogota, Colombia

[9] ACN, Neurol, Bogota, Colombia

[10] ACN, Manizales, Colombia

[11] ACN, Medellin, Colombia

来源：

JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P255

引用

页数：2

共 50 条

[1] GalcanezumAb for prevention of high frequency episodic and chronic migraine in the Real Life in ITaly: a multicenter prospective cohort study (the GARLIT study)
Vernieri, F.
Altamura, C.
Brunelli, N.
Costa, C. M.
Aurilia, C.
Egeo, G.
Fofi, L.
Favoni, V.
Pierangeli, G.
Lovati, C.
Aguggia, M.
Bertuzzo, D.
D'Onofrio, F.
Doretti, A.
Di Fiore, P.
Frediani, F.
Finocchi, C.
Rao, R.
Di Cola, F. Schiano
Bono, F.
Ranieri, A.
Albanese, M.
Cevoli, S.
Barbanti, P.
CEPHALALGIA, 2021, 41 (1_SUPPL) : 29 - 30
[2] Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
Fabrizio Vernieri
Claudia Altamura
Nicoletta Brunelli
Carmelina Maria Costa
Cinzia Aurilia
Gabriella Egeo
Luisa Fofi
Valentina Favoni
Giulia Pierangeli
Carlo Lovati
Marco Aguggia
Florindo d’Onofrio
Alberto Doretti
Paola Di Fiore
Cinzia Finocchi
Renata Rao
Francesco Bono
Angelo Ranieri
Maria Albanese
Sabina Cevoli
Piero Barbanti
The Journal of Headache and Pain, 2021, 22
[3] Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
Vernieri, Fabrizio
Altamura, Claudia
Brunelli, Nicoletta
Costa, Carmelina Maria
Aurilia, Cinzia
Egeo, Gabriella
Fofi, Luisa
Favoni, Valentina
Pierangeli, Giulia
Lovati, Carlo
Aguggia, Marco
d'Onofrio, Florindo
Doretti, Alberto
Di Fiore, Paola
Finocchi, Cinzia
Rao, Renata
Bono, Francesco
Ranieri, Angelo
Albanese, Maria
Cevoli, Sabina
Barbanti, Piero
JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01):
[4] Effectiveness and safety of erenumab and galcanezumab in the prevention of chronic and episodic migraine: A retrospective cohort study
Viudez-Martinez, Adrian
Pascual-Carrasco, Angela
Beltran-Blasco, Isabel
Hernandez-Lorido, Raquel
de Apodaca, Rosa F. Ruiz
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (06) : 814 - 823
[5] The real-life early and continuative response to Galcanezumab in chronic migraine: 3-month analysis of the multicenter prospective cohort GARLIT study
Altamura, C.
Brunelli, N.
Costa, C. M.
Aurilia, C.
Egeo, G.
Fofi, L.
Favoni, V.
Pierangeli, G.
Messina, R.
Filippi, M.
Colombo, B.
Lovati, C.
Aguggia, M.
Bertuzzo, D.
D'Onofrio, F.
Doretti, A.
Di Fiore, P.
Frediani, F.
Finocchi, C.
Rao, R.
Di Cola, F. Schiano
Bono, F.
Ranieri, A.
Albanese, M.
Cevoli, S.
Barbanti, P.
Vernieri, F.
JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 123 - 123
[6] The real-life early and continuative response to Galcanezumab in chronic migraine: 3-month analysis of the multicenter prospective cohort GARLIT study
Altamura, C.
Brunelli, N.
Costa, C. M.
Aurilia, C.
Egeo, G.
Fofi, L.
Favoni, V.
Pierangeli, G.
Messina, R.
Filippi, M.
Colombo, B.
Lovati, C.
Aguggia, M.
Bertuzzo, D.
D'Onofrio, F.
Doretti, A.
Di Fiore, P.
Frediani, F.
Finocchi, C.
Rao, R.
Di Cola, F. Schiano
Bono, F.
Ranieri, A.
Albanese, M.
Cevoli, S.
Barbanti, P.
Vernieri, F.
CEPHALALGIA, 2021, 41 (1_SUPPL) : 183 - 184
[7] The First, Italian, Multicenter, Real-life Study with Erenumab in the Prevention of High Frequency Episodic and Chronic Migraine
Barbanti, Piero
Aurilia, Cinzia
Cevoli, Sabina
Colombo, Bruno
Frediani, Fabio
Bono, Francesco
Grazzi, Licia
D'Amico, Domenico
Salerno, Antonio
Mercuri, Bruno
Carnevale, Antonio
Vollono, Catello
Egeo, Gabriella
Fofi, Luisa
Altamura, Claudia
Costa, Carmen
Brunelli, Nicoletta
Fallacara, Adriana
Pierangeli, Giulia
Favoni, Valentina
Messina, Roberta
Filippi, Massimo
Di Fiore, Paola
Santangelo, Domenico
Vernieri, Fabrizio
NEUROLOGY, 2020, 94 (15)
[8] Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study
Barbanti, Piero
Aurilia, Cinzia
Egeo, Gabriella
Fofi, Luisa
Cevoli, Sabina
Colombo, Bruno
Filippi, Massimo
Frediani, Fabio
Bono, Francesco
Grazzi, Licia
Salerno, Antonio
Mercuri, Bruno
Carnevale, Antonio
Altamura, Claudia
Vernieri, Fabrizio
HEADACHE, 2021, 61 (02): : 363 - 372
[9] Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 24-week, multicenter, real-life, cohort study (the FRIEND study)
Egeo, Gabriella
Aurilia, Cinzia
Torelli, Paola
d'Onofrio, Florindo
Laura, Di Clemente
Finocchi, Cinzia
Di Fiore, Paola
Sette, Giuliano
Vernieri, Fabrizio
Grazzi, Licia
Le Pera, Domenica
Valenza, Alessandro
Albanese, Maria
Viticchi, Giovanna
Proietti, Stefania
Bonassi, Stefano
Barbanti, Piero
CEPHALALGIA, 2022, 42 (1_SUPPL) : 100 - 101
[10] Fremanezumab in the prevention of high-frequency episodic and chronic migraine: FRIEND (FRemanezumab In rEal world stuDy), the first Italian multicenter, prospective real-life study
Fofi, L.
Egeo, G.
Aurilia, C.
Costa, C. M.
Altamura, C.
Vernieri, F.
Albanese, M.
D'Onofrio, F.
Di Clemente, L.
Zucco, M.
Di Fiore, P.
Frediani, F.
Messina, R.
Colombo, B.
Filippi, M.
Bono, F.
Manzo, L.
Carnevale, A.
Barbanti, P.
Proietti, S.
Bonassi, S.
CEPHALALGIA, 2021, 41 (1_SUPPL) : 171 - 172

← 1 2 3 4 5 →